2月23日晚间,山河药辅(深市代码:300452)公告,股东上海复星医药产业发展有限公司(以下简称“复星医药”)因经营需要,拟减持本公司股份不超过697.8万股,即不超过公司总股本的3%。山河药辅表示,复星医药拟减持时间为2025年3月18日至6月15日,拟减持价格根据减持时市场价格及相关规定确定,不低于发行价。目前,复星医药持有山河药辅2392.81万股,占该公司总股本比例为10.20%,为其...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.